PT100668B - Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos - Google Patents

Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos Download PDF

Info

Publication number
PT100668B
PT100668B PT100668A PT10066892A PT100668B PT 100668 B PT100668 B PT 100668B PT 100668 A PT100668 A PT 100668A PT 10066892 A PT10066892 A PT 10066892A PT 100668 B PT100668 B PT 100668B
Authority
PT
Portugal
Prior art keywords
corydalis
extract
extracts
pharmaceutical composition
eschsoltzia
Prior art date
Application number
PT100668A
Other languages
English (en)
Portuguese (pt)
Other versions
PT100668A (pt
Inventor
Werner Schneider
Erich F Elstner
Elisabeth Kleber
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of PT100668A publication Critical patent/PT100668A/pt
Publication of PT100668B publication Critical patent/PT100668B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT100668A 1991-07-09 1992-07-08 Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos PT100668B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (https=) 1991-07-09 1991-07-09

Publications (2)

Publication Number Publication Date
PT100668A PT100668A (pt) 1993-09-30
PT100668B true PT100668B (pt) 1999-08-31

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100668A PT100668B (pt) 1991-07-09 1992-07-08 Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos

Country Status (26)

Country Link
US (1) US5308619A (https=)
EP (1) EP0535317B1 (https=)
JP (1) JPH085796B2 (https=)
KR (1) KR100225010B1 (https=)
AT (1) ATE139446T1 (https=)
AU (1) AU652262B2 (https=)
CA (1) CA2072950A1 (https=)
CZ (1) CZ279915B6 (https=)
DE (2) DE4122706C1 (https=)
DK (1) DK0535317T3 (https=)
EE (1) EE03169B1 (https=)
EG (1) EG20140A (https=)
ES (1) ES2088053T3 (https=)
GR (1) GR3020289T3 (https=)
HU (1) HUT61668A (https=)
IE (1) IE74691B1 (https=)
IL (1) IL102410A (https=)
MD (1) MD1139G2 (https=)
MX (1) MX9204011A (https=)
PT (1) PT100668B (https=)
RU (1) RU2072859C1 (https=)
SI (1) SI9200138A (https=)
SK (1) SK279531B6 (https=)
UA (1) UA26971C2 (https=)
YU (1) YU48554B (https=)
ZA (1) ZA925059B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
BR9909110A (pt) * 1998-03-26 2000-12-12 Phytopharm Plc Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
ATE405665T1 (de) * 1999-03-11 2008-09-15 Zeachem Inc Verfahren zur herstellung von äthanol
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
CN1938257A (zh) * 2004-01-29 2007-03-28 齐凯姆公司 有机酸的回收
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (https=) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Also Published As

Publication number Publication date
IE74691B1 (en) 1997-07-30
CA2072950A1 (en) 1993-01-10
IE922226A1 (en) 1993-01-13
DK0535317T3 (da) 1996-07-15
KR930001926A (ko) 1993-02-22
PT100668A (pt) 1993-09-30
SK279531B6 (sk) 1998-12-02
CZ214392A3 (en) 1993-02-17
GR3020289T3 (en) 1996-09-30
HU9202274D0 (en) 1992-10-28
RU2072859C1 (ru) 1997-02-10
EP0535317A1 (de) 1993-04-07
JPH085796B2 (ja) 1996-01-24
SK214392A3 (en) 1994-11-09
SI9200138A (en) 1993-03-31
IL102410A0 (en) 1993-01-14
AU1937092A (en) 1993-01-14
UA26971C2 (uk) 2000-02-28
HUT61668A (en) 1993-03-01
YU67492A (sr) 1996-01-09
KR100225010B1 (ko) 1999-10-15
ZA925059B (en) 1993-04-28
YU48554B (sh) 1998-11-05
EP0535317B1 (de) 1996-06-19
AU652262B2 (en) 1994-08-18
IL102410A (en) 1998-02-22
JPH0753392A (ja) 1995-02-28
EG20140A (en) 1997-07-31
EE03169B1 (et) 1999-04-15
ES2088053T3 (es) 1996-08-01
MD1139F2 (en) 1999-01-31
DE4122706C1 (https=) 1993-03-04
US5308619A (en) 1994-05-03
ATE139446T1 (de) 1996-07-15
MX9204011A (es) 1993-07-01
DE59206608D1 (de) 1996-07-25
MD950171A (en) 1996-06-28
MD1139G2 (ro) 1999-10-31
CZ279915B6 (cs) 1995-08-16

Similar Documents

Publication Publication Date Title
Prange et al. L-tryptophan in mania: Contribution to a permissive hypothesis of affective disorders
EP3332793B1 (fr) Composition comprenant un melange d'extraits vegetaux ou un melange de molecules contenues dans ces vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
EP1377278B1 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
PT100668B (pt) Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos
Sung et al. Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men
KR100877600B1 (ko) 메타독신 및 마늘유를 유효성분으로 함유하는 알코올성지방간 및 지방간성 간염의 예방 및 치료용 약학 조성물
CZ147494A3 (en) Pharmaceutical preparation and process for preparing thereof
Jailer et al. The influence of orally administered alkali and acid on the renal excretion of quinacrine, chloroquine and santoquine
Medon et al. Influence of quipazine, a potential anti-parkinsonian agent on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro
US20020058712A1 (en) Treatment of fibromyalgia with ubiquinone 10 and succinic acid
Hashim Fauzy et al. Piper sarmentosum leaves aqueous extract attenuates vascular endothelial dysfunction in spontaneously hypertensive rats
Wirz-Justice et al. Increased platelet serotonin in bipolar depression and hypomania
Dubey et al. Acute renal failure: a complication of Datura poisoning
KR0168748B1 (ko) 혈당 강하용 인삼 음료와 소프트 캡슐
RU2146529C1 (ru) Набор антиалкогольных средств
EP1150669A1 (en) L-arginine based formulations for treating diseases and methods of using same
US20230111153A1 (en) Compositions derived from salvia hispanica seeds
LT3355B (en) Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
JP2008074796A (ja) 抗糖尿病食品
CN110548150A (zh) 一种复方药物组合物在制备治疗急性肾损伤药物中的应用
KR100523446B1 (ko) 유향으로부터 얻은 5' 에이엠피-활성화 단백질 인산화효소 활성용 추출물
KR100773246B1 (ko) 연령초 추출물을 유효성분으로 함유하는 비만 억제 및 혈당강하용 조성물
Ask Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum
WO2015092043A1 (fr) Combinaison de bézafibrate et de resvératrol ou de dérivés de resvératrol pour le traitement et la prévention des maladies impliquant un dysfonctionnement énergétique des mitochondries
Janowsky et al. Neurotransmitter Receptor-Mediated Myo-Inositol 1-Phosphate Accumulation in Hippocampal Slices

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930507

FG3A Patent granted, date of granting

Effective date: 19990511

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011130